Table 6. Threshold analysis comparing the costs of HPV DNA testing to actual and hypothetical Pap screening (Functional Limit scenario).
HPV DNA versus Pap 1 | HPV DNA versus Pap 2 | |||
---|---|---|---|---|
Pap 1 | HPV DNA | Pap 2* | HPV DNA | |
Screening cost reduced to: | ||||
Lab cost (US$) | No change | 1.00 | No change | 12.93 |
Total cost (US$) | No change | 3.60 | No change | 15.54 |
True cases detected | 298 | 361 | 373 | 361 |
Total cost for screening** | 38,915 | 55,083 | 69,865 | 69,320 |
Cost per true case detected | 130.63 | 152.51 | 187.52 | 191.92 |
* Note that this method is not currently allowed under existing guidelines, but was presented as a hypothetical alternative in the validation study.
** For initial screen plus colposcopic biopsy when indicated. Excludes colposcopic biopsy for VIA because not clinically relevant.